A Lithuanian medical degree costs about €78,300 in tuition. Whether it counts back home rides on one two-minute check almost nobody makes for you

Every year, agents send thousands of Indian students who cleared NEET but not the cutoff for a government seat, or who cannot afford a management-quota seat at a private Indian college, toward a handful of Eastern European countries that will take them into a six-year medical programme almost on the strength of the entrance test alone. Lithuania is one of the newer names on that list, and on paper it looks like the strongest of them: European Union membership, an English-taught curriculum, no donation on top of the published fee, and universities that genuinely teach medicine rather than run a visa-issuing operation with a classroom attached. All of that can be true and the degree can still be worth nothing back in India, and the reason has nothing to do with Lithuania. It has to do with one line of paperwork almost no agent walks a family through before the deposit is paid.

What Lithuania is actually offering

The Lithuanian University of Health Sciences in Kaunas, LSMU, runs a six-year integrated Medicine programme taught entirely in English, leading to a qualification equivalent to an MBBS. For the 2026/27 intake, tuition is published at €12,800 a year for years one through three and €13,300 a year for years four through six, a total of €78,300 across the full degree, paid to the university directly under a study contract rather than negotiated with an agent. Admission runs through LSMU's own online entrance test, thirty biology questions and thirty chemistry questions, multiple choice, ninety minutes, followed by a short interview. Applicants who already hold certain recognised results are exempt from sitting it:

• , A Levels: grade C or better in both Biology and Chemistry
• , IB Diploma: 5 or higher at Higher Level in the relevant sciences
• , UCAT: 2100 or above
• , MCAT: 511 or above
• , IMAT: 57 or above

English proficiency is asked for separately, an IELTS score above 5.5, a CEFR B1 certificate, or an equivalent PTE or Duolingo result. For the current cycle, applications opened on 1 November 2025, the entrance test window began 13 January 2026, and the deadlines to apply run to 6 July 2026 for the primary round and 30 July 2026 for the secondary one, against a non-refundable €150 application fee. None of this resembles the opaque, cash-heavy admission process that makes a private Indian medical seat cost what it does. It is a real university publishing a real fee schedule and a real entrance test, which is exactly why it is so easy to stop asking questions once you have read this far.

The line that decides whether any of it counts

Under India's Foreign Medical Graduate Licentiate Regulations, the National Medical Commission will only let you sit the licensing exam that lets you practise in India if the medical school awarding your degree appears in the WHO and World Federation for Medical Education's World Directory of Medical Schools, WDOMS, at the relevant dates around your admission and graduation. This is not a country-level rule and it is not a reputation test. It is a specific database entry for a specific faculty, checked at wdoms.org, and it can change. A university can lose its listing, restructure a faculty, or run a joint programme that is not the same legal entity as the one actually listed, and a general web search or an agent's brochure will not reliably tell you which one you are enrolling into. Multiple independent sources describe Lithuanian medical faculties, LSMU included, as carrying a current WDOMS listing, which is a genuinely good sign. It is also exactly the kind of claim that is worthless coming from us, or from any agent, because the only version of this fact that protects your six years and your money is the one you pull yourself, directly from the free public search at wdoms.org, for the exact faculty name on the exact offer letter in front of you, on the day you accept it, and again shortly before you graduate. That habit, not the country you pick, is what actually keeps a foreign medical degree from turning into six wasted years.

The exam this cohort graduates into is not the one being advertised

Most Lithuania and MBBS-abroad marketing leans hard on FMGE pass-rate statistics, the Foreign Medical Graduate Examination that returning graduates currently have to clear before they can register to practise in India. Those numbers describe an exam that is already being phased out. India is replacing FMGE with the NExT, the National Exit Test, a two-step, competency-based exam quite different in format from FMGE's single paper, and NMC has confirmed NExT applies to graduates of Indian medical colleges from 2027 onward. The commission's own 2026 draft regulations keep FMGE in place for foreign medical graduates for now, with no confirmed date yet for switching FMGs onto NExT instead. A student enrolling at a Lithuanian medical school in 2026 will graduate around 2032. By then, the exam that actually decides their career in India is far more likely to be some version of NExT than the FMGE pass rate currently being quoted at them. Build your plan around the exam you will actually sit, not the one an old statistic happens to describe.

What it costs, against the real alternative

Set the €78,300 in tuition against a Kaunas cost of living, where a nearby public university's own estimate for its international students runs roughly €300 to €1,000 a month depending on lifestyle, and a university dormitory room typically costs €80 to €150 a month, well below the €500 to €800 that a private room or shared flat runs in the city. Budgeted modestly, six years of living costs land somewhere in the €35,000 to €45,000 range on top of tuition, putting the realistic all-in cost of the degree at roughly €115,000 to €125,000 over six years. That is a real number, not a marketing one, and it still comes in well under what a management-quota or NRI-quota seat costs at most private medical colleges in India once the capitation payment that sits on top of the official fee is counted in, a payment Lithuania's system does not have at all. The saving is genuine. It just is not the whole story, because a cheaper degree that never gets you registered to practise is not a saving, it is a six-year detour.

None of this makes Lithuania a bad choice, and none of it makes the WDOMS check or the NExT transition a reason to avoid it. It makes Lithuania a genuinely serious option for a student who could not get a government medical seat in India, cannot or will not pay a capitation donation for a private one, and is prepared to do two things almost nobody in this market bothers to do: verify the exact faculty's WDOMS listing themselves before paying a deposit and again before graduating, and plan their licensing path around NExT rather than a fading FMGE pass-rate statistic. Someone unwilling to do that homework, or hoping a European medical degree is a shortcut around India's own registration process, will find that Lithuania keeps its side of the bargain and India's regulator still asks its own questions afterward.

Tuition, deadlines and entrance-test terms are LSMU's own published figures for 2026/27 and change year to year; confirm the current cycle directly with the university before relying on them. Always verify WDOMS status yourself at wdoms.org for the exact faculty on your own offer letter, since a listing can change and a general claim about a country or a university brand is not the same thing as a current entry for the specific programme you are joining.